\
&
Contact us
\
&
Contact us
Published on | 13 minutes ago
ProgrammesEP PerMed has launched a new Stakeholder Forum to foster early collaboration between public research, industry, and other key stakeholders. The Forum provides a networking platform to accelerate the translation of personalised medicine research into clinical practice and commercial applications.
The European Partnership for Personalised Medicine (EP PerMed) has recently launched the EP PerMed Stakeholder Forum, bringing together researchers, clinicians, companies, patients, regulatory stakeholders, and other key players in personalised medicine on a single platform to support the translation of research findings into clinical practice and marketable applications.
The Stakeholder Forum aims to offer simple, low-barrier access to initiate new collaborations and jointly advance the implementation of personalised medicine. The platform is intended for the broader personalised medicine community. More information and registration is available here: Home | EP PerMed Stakeholder Forum .
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The European Holocaust Research Infrastructure Implementation Phase (EHRI-IP) project was funded under Horizon Europe call topic HORIZON-INFRA-2023-DEV-01-02. The project duration was two years and came to an end in February 2026. The main objective of the EHRI-IP project was to undertake all necessary legal, financial and strategic work to have a permanent organisation or ERIC (European Research Infrastructure Consortium) fully operational by the end of the implementation phase. The project consortium consisted of 14 partners from 13 countries. Read more about the project and the contribution of Flemish partner Kazerne Dossin in this testimonial.
